Upload
coarsem-adman
View
214
Download
0
Embed Size (px)
Citation preview
8/2/2019 Psychedelic Medicine Eflyer 2010
1/5
Psychedelic Medicine: New Evidence forHallucinogenic Substances asTreatments [2 volumes]
Edited by Michael J. Winkelman, Ph.D. and Thomas B. Roberts, Ph.D
Roberts's faculty webpage:
http://www.cedu.niu.edu/lepf/edpsych/faculty/roberts/index_roberts.html
Winkelmans' website: http://www.public.asu.edu/~atmxw/Psychedelic substances present in nature have been used by humans across hundredsof years to produce mind-altering changes in thought, mood, and perception - changeswe do not experience otherwise except rarely in dreams, religious exaltation, orpsychosis. U.S. scientists were studying the practical and therapeutic uses forhallucinogens, including LSD and mescaline, in the 1950s and 1960s supplied by largemanufacturers including Sandoz. But the government took steps to ban all humanconsumption of hallucinogens, and thus the research. By 1970s, all human testing wasstopped. Medical concerns were not the issue, the ban was moved by social concerns,
not the least of which were created by legendary researcher Timothy Leary, apsychologist who advocated free use of hallucinogens by all who desired. Nationwide,however, a cadre of scholars and researchers has persisted in pushing the federalgovernment to again allow human testing. And the moratorium has been lifted. The FDAhas begun approving hallucinogenic research using human subjects. In thesegroundbreaking volumes, top researchers explain the testing and research underway touse - under the guidance of a trained provider - psychedelic substances for betterphysical and mental health.
http://www.cedu.niu.edu/lepf/edpsych/faculty/roberts/index_roberts.htmlhttp://www.cedu.niu.edu/lepf/edpsych/faculty/roberts/index_roberts.htmlhttp://www.public.asu.edu/~atmxw/http://www.cedu.niu.edu/lepf/edpsych/faculty/roberts/index_roberts.htmlhttp://www.public.asu.edu/~atmxw/8/2/2019 Psychedelic Medicine Eflyer 2010
2/5
These books are a comprehensive and scholarly review of the current status of thetherapeutic potential of hallucinogens. The contributors represent an outstandinggroup of scientists, scholars and clinicians, most of whom have had directexperience using and administering these drugs in either therapeutic or religiouscontexts. The result is an impressive collection. The authors provide scholarlyhistorical reviews of the use of these drugs, as well as detailed instructions and
advice for the clinician on how to administer these drugs safely and effectively ina therapeutic context. The authors provide a balanced view and acknowledge themany risks and pitfalls of improper use of these drugs. Likely to be of interest toscientists, clergy, mental health professionals, and anyone interested in the mind.It provides an up to date review of the status of h allucinogens in modernmedicine, as well as a historical review of their status in the past. It is highlyrecommended. --Harriet de Wit, PhD Professor, Department of Psychiatry TheUniversity of Chicago
Until they were caught up in the cultural revolution of the 1960s, hallucinogens werebeing seriously examined by top researchers for their potential to alleviate many human
ills. The contributors to this volume make a persuasive case that science should now domore to pursue these questions. -- Professor Jonathan D. Moreno, University ofPennsylvania Centerfor Bioethics
Roberts and Winkelman have assembled one of the most impressive andcomprehensive collection of writings in the field of psychedelic medicine. Thechapters, written by first-rate academic scholars, are rigorous and clear. Thetopics range from neuroscience to the legal, spiritual, medicinal, and ethicalimplications of using this novel class of agents. This book is an invaluableresource for educators, clinicians, and policy makers who are interested inrejuvenating the field of psychedelic research.
-- Stephen Ross, M.D. Assistant Clinical Professor, Psychiatry, NYU School ofMedicine Director, Division of Alcoholism and Drug Abuse, Bellevue Hospital
Associate Director, Addiction Psychiatry Fellowship, NYU School of Medicine
These volumes present fresh ideas for using psychedelic drugs as therapeutic agents totreat some of the most intractable of psychological ailments. As the authors make clear,the ability of these substances to facilitate direct experiential access to our deepestthoughts, feelings, and spirituality makes them uniquely suited for this purpose.Undoubtedly, their amazing healing potential has yet to be fully realized. Thanks to theseforward-thinking educators, researchers, and clinicians, we now have new paths toexplore in the cure for old diseases. -- Nicholas V. Cozzi, Ph.D. Department ofPharmacology University of Wisconsin School of Medicine and Public Health
Psychedelic Medicines: New Evidence for HallucinogenicSubstances as Treatments
8/2/2019 Psychedelic Medicine Eflyer 2010
3/5
Winkelman, Michael, & Roberts, Thomas B. (editors) (2007).Westport, CT: Praeger/Greenwood Publishers
Volume I: Psychedelic Medicine: Social, Clinical and LegalPerspectives
Preface-Warning. Thomas B. RobertsEditors Overview ofPsychedelic Medicines Volume 1. Michael Winkelman
Section I: The Social and Clinical ContextChapter 1: Therapeutic Bases of Psychedelic Medicines: PsychointegrativeEffects. Michael WinkelmanChapter 2: The Healing Vine: Ayahuasca as Medicine in the 21st Century.Dennis McKenna
Chapter 3: Contemporary Psychedelic Therapy: An Overview. Torsten PassieChapter 4: Therapeutic Guidelines: Dangers and Contra-Indications in Therapeutic
Applications of Hallucinogens. EdeFrecska
Section II: Medical Applications
Chapter 5: Response of Cluster Headaches to Psilocybin and LSD. Andrew Sewell &John H. HalpernChapter 6: Psilocybin Treatment of Obsessive- Compulsive Disorder. F. A. Moreno &P. L. DelgadoChapter 7: Therapeutic Uses of MDMA. George Greer & Requa TolbertChapter 8: MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic StressDisorder. Michael MithoeferChapter 9: Psychedelic Drugs for the Treatment of Depression. Michael Montagne
Chapter 10: Marijuana and AIDS. Donald AbramsChapter 11: The Use of Psilocybin in Patients with Advanced Cancer and ExistentialAnxiety. C. Grob
Section III: Legal Aspects of the Medical UseChapter 12: Psychedelic Medicine and the Law. Richard BoireChapter 13: The Legal Bases for Religious Peyote Use. Kevin FeeneyChapter 14: The Supreme Courts Psychedelic Case. Alberto Groisman & Marlene deRiosChapter 15: Conclusions. Michael Winkelman & Thomas B. Roberts
Volume II: Psychedelic Medicine: Addictions Medicine andTranspersonal Healing
Preface- LancetEditorialChapter 1: Introduction The Adventure Continues. Thomas B. Roberts
Section I: Treating Substance Abuse
8/2/2019 Psychedelic Medicine Eflyer 2010
4/5
Chapter 2: Hallucinogens in the Treatment of Alcoholism and OtherAddictions. J. H. HalpernChapter 3: Addiction, Despair, and the Soul: Psychedelic Psychotherapy. R.
Yensen & D. DryerChapter 4: The Therapeutic Use of Peyote in the Native American Church.
Joseph Calabrese
Chapter 5:Ibogaine and Substance Abuse Rehabilitation. Kenneth R. Alper &Howard LotsofChapter 6:Ketamine Psychedelic Psychotherapy. Evgeny Krupitsky & Eli KolpChapter 7: Ayahuasca Treatment of Cocaine-Paste Addiction. Jacques Mabit
Section II: Guidelines for Psychotherapeutic ApplicationsChapter 8: The Ten Lessons of Psychedelic Psychotherapy Rediscovered.Neal GoldsmithChapter 9: Therapeutic Guidelines from Shamanic Traditions. MichaelWinkelmanChapter 10: Common Processes in Psychospiritual Change. Sean HouseChapter 11: Preliminary Remarks on Interpreting Resistance to Psychedelic
Insights. Dan Merkur
Section III: Transpersonal Dimension of Healing with PsychedelicMedicines
Chapter 12: Psychedelics in Psychological Health and Growth. Roger Walsh &Charles GrobChapter 13: Psilocybin Can Occasion Mystical-type Experiences HavingSubstantial and Sustained Personal Meaning and Spiritual Significance. R.Griffiths, W. Richards, U. McCann & R. Jesse.Chapter 14: Remarkable Healing During Psychedelic Psychotherapy.Stanislav GrofChapter 15: Transpersonal Healing with Hallucinogens. Roger Marsden &David LukoffChapter 16: Conclusions and Future Recommendations: The Wider Contexts.
Thomas B. RobertsAuthor biographiesIndex
List Price: $200.00 0-275-99023-0/978-0-275-99023-7 Pages: Publication: 6/30/2007To order, visit www.greenwood.com, call 1-800-225-5800, or use this order form:
8/2/2019 Psychedelic Medicine Eflyer 2010
5/5
ISBN Title Price Qty
Total
0-275-99023-0978-0-275-99023-7
Psychedelic Medicine[Two Volumes]
$200.00
If paying by check, please add shipping andhandling: U.S. residents add 10%; Canada
residents, add 12%; $8.00 minimum.IL, MA, MD, MO, NJ, VT residents add sales taxon subtotal. CO, CT, PA, & SD residents addsales tax on subtotal plus shipping charges.Canada residents add GST tax. Enclose tax-exempt certificate if applicable.
Subtotal Shipping
Sales Tax Total
Name:
Address:
City:
State:
Zip:
Telephone:
Email:
Check enclosed made payable toGreenwood Publishing Group
Charge Credit Card: VISA MCAMEXCredit Card #:
Expiration Date:
Signature (required):